Physician profile
John H Bishay
NPI 1992933758
$137,786.02
in general payments reported to CMS, 2019-2025
52 companies · $66K in 2025
The $66K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,394 · 2020: $3,289 · 2021: $3,802 · 2022: $11K · 2023: $30K · 2024: $21K · 2025: $66K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $65K · Consulting Fee: $33K · Travel and Lodging: $8,294 · Food and Beverage: $6,783 · Education: $4,100 · Gift: $42.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $64,705.00 |
| Consulting Fee | $32,566.10 |
| Travel and Lodging | $8,294.10 |
| Food and Beverage | $6,782.54 |
| Education | $4,099.99 |
| Gift | $42.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $62,507.11 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Janssen Biotech, INC. | $21,593.96 | 2019-2025 | Carvykti, Rybrevant, Erleada |
| Intuitive Surgical, INC. | $13,069.34 | 2019-2024 | Da Vinci Surgical System |
| Janssen Scientific Affairs, LLC | $11,178.64 | 2019-2025 | Erleada, Pipeline |
| Astrazeneca Pharmaceuticals Lp | $6,310.96 | 2020-2025 | Imfinzi |
| Astellas Pharma US INC | $3,962.61 | 2019-2025 | Padcev, Xtandi, Myrbetriq |
| Ferring Pharmaceuticals INC. | $2,556.97 | 2023-2025 | Adstiladrin |
| Neotract INC. | $2,381.18 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $2,068.54 | 2019-2025 | |
| Boston Scientific Corporation | $1,957.02 | 2019-2025 | Spaceoar Vue System - 10ml, Advance Xp, Ams 700 Cxr Rte Kit |
| Janssen Pharmaceuticals, INC | $1,556.25 | 2025 | |
| Teleflex LLC | $1,451.24 | 2021-2024 | Urolift |
| Procept Biorobotics Corporation | $1,000.51 | 2021-2025 | Aquabeam Robotic System, Aquabeam System |
| Axonics, INC. | $890.83 | 2020-2023 | Axonics |
| Dendreon Pharmaceuticals LLC | $883.96 | 2019-2025 | Provenge |
Show all 51 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bishay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.